marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GW Pharmaceuticals plc (GWPH) Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.

GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.…

Trulieve Cannabis Corp. (TCNNF) Reports Record Second Quarter 2021 Earnings

Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets…

Tilray Brands, Inc. (TLRY) Reports Third Quarter Fiscal Year 2022 Financial Results

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results Tilray…